Skip to main content
Caplight Logo









53Biologics

53Biologics

Private
ValladolidHealthcare & Life Scienceshttps://53biologics.com/

Last Round

Strategic

Mar 25, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

53Biologics is a biotechnology company that operates as a Contract Development and Manufacturing Organization (CDMO) providing services from preclinical development to GMP manufacturing for biological products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

Contract Development and Manufacturing OrganizationCDMOBiologics CDMOBiologics manufacturingGMP manufacturingPlasmid DNA manufacturingpDNA manufacturingRNA manufacturingRecombinant protein productionAseptic fill & finishDrug substance manufacturingEnd-to-end manufacturingBiopharmaceutical servicesCell line developmentProcess developmentCell banking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

53Biologics Comparables

Compare 53Biologics with similar companies based on industry and business-model similarity.

53Biologics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
3PBIOVIAN
86%
Biomay AG
79%
HAS Healthcare Advanced Synthesis SA
78%

53Biologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMar 25, 2026
VC RoundSep 10, 2021

53Biologics Investors

Notable investors and investment history

53Biologics investors
InvestorRounds
InvereadyVC Round, Strategic
Ren Life SciencesStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 47% MoM, reaching 4.7K.

  • Mar 25, 2026

    Led by Ren Life Sciences with participation from Inveready.

53Biologics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

53Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 53Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersValladolid
Employee Range46
Year Founded2019
Last FundingMar 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?